Further, miR-126 may alter cellular mechanisms involved in cancer pathogenesis by suppressing translation of numerous validated target genes such as PI3K, KRAS, EGFL7, CRK, ADAM9, HOXA9, IRS-1, SOX-2, SLC7A5 and VEGF. This evidence concerns the gene IRS1 and cancer.